Performance evaluation of in-house magnetized red cells prepared by Regional Blood Centre II Lopburi Province, Thai Red Cross Society for ABO serum grouping using the QWALYS® 3 EVO automated analyzer
Keywords:
ABO serum grouping, Erythrocyte-magnetized technology, In-house magnetized cells, การตรวจหมู่โลหิต เอ บี โอ ในซีรัม, เครื่องคลอลิส อีโว, เทคโนโลยีการทำให้เม็ดเลือดแดงมีความเป็นแม่เหล็ก, การผลิตเม็ดเลือดแดงที่มีความเป็นแม่เหล็กขึ้นมาเอง, QWALYS 3 EVOAbstract
Abstract:
Introduction: ABO blood group testing using the QWALYS® 3 EVO analyzer employs erythrocyte-magnetized technology (EMT) with HEMALYS A1, B cells manufactured, imported from France. However, dependency on imported products poses risks, especially during crises, including the COVID-19 pandemic, which caused delivery delays and quality issues including hemolysis. Objective: This study aimed to evaluate the performance of ready-to-use in-house magnetized A1, B and O cells for ABO serum grouping. Materials and Methods: This prospective experimental study evaluated the performance of two formulations of in-house magnetized A1, B and O cells: standard formula (diluentlys 5 mL + magnelys reagent 75 µL + standard cells 80 µL each) and EDTA-supplemented formula (diluentlys 4 mL + magnelys reagent 75 µL + standard cells 80 µL each + EDTA 1.8 g/L, 1 mL). Performance was compared with HEMALYS A1, B using 1,123 known samples and 560 routine unknown samples. Cell stability was evaluated for 35 days. Testing was performed on the QWALYS® 3 EVO analyzer and confirmed with standard tube test (STT) for uninterpreted reactions. Results: Among 1,123 known samples, in-house magnetized cells with EDTA showed 98.04% accuracy (1,101 samples), comparable to HEMALYS A1, B cells at 98.13% (1,102 samples), with very high agreement (Kappa = 0.9462). Standard in-house magnetized cells without EDTA showed 90.29% accuracy (1,014 samples) with Kappa = 0.8412. Parallel testing with unknown samples showed 100% concordance. Both formulations demonstrated good stability for 35 days without contamination or hemolysis. Conclusion: In-house magnetized cells with EDTA demonstrated performance equivalent to imported products and can serve as a cost-effective alternative to reduce import dependency and enhance national blood service system security efficiently.
Downloads
References
Reid M, Shine I. The discovery and significance of the blood groups. Massachusetts: SBB Books; 2012.
International Society of Blood Transfusion. Red cell immunogenetics and blood group terminology [Internet]. Amsterdam: ISBT; [cited 2025 Apr 3]. Available from: https://www.isbtweb.org/isbt-working-parties/rcibgt.html.
Pechchantorn, S. Blood groups. Bangkok: The Thai Society of Hematology. Available from: https://tsh.or.th/Knowledge/Details/69 1 Jan, 2024.
E for L International Co. Standard operation procedure for QWALYS® 3 EVO analyzer. France: Diagast; 2014.
QWALYS® 3 EVO EM technology [Internet]. France: Diagast; [cited 2024 Jan 1]. Available from: https://www.diagast.com/en/automatons-reagents/automate-methods/QWALYS-3-evo-en/em-technology/
Bouix O, Ferrera V, Delamaire M, Redersdorff JC, Roubinet F. Erythrocyte-magnetized technology: an original and innovative method for blood group serology. Transfusion. 2008;48:1878-85.
Schoenfeld H, Bulling K, Von Heymann C, Neuner B, Kalus U, Kiesewetter H, et al. Evaluation of immunohematologic routine methods using the new Erythrocyte-magnetized technology on the QWALYS 2 system. Transfusion. 2009;49:1347-52.
Vashiraporn Y, Kasama E, Sathit T. Preparation of magnetized red cells for ABO serum grouping by Qwalys 3 blood grouping automation. J Hematol Transfus Med. 2020;30:119-27.
Roback JD, Combs MR, Grossman BJ, Harris T, Hillyer CD, eds. Technical manual. 16th ed. Bethesda, MD: AABB; 2008. p. 368-72.
Roback JD, Combs MR, Grossman BJ, Harris T, Hillyer CD, eds. Technical manual. 16th ed. Bethesda, MD: AABB; 2008. p. 899-900.
Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
Banerjee C, Capozzoli M, McSweeney L, Sinha D. Beyond kappa: a review of interrater agreement measures. Can J Stat. 1999;27:3-23.
Reis KJ, Chachowski R, Cupido A, Davies D, Jakway J, Setcavage TM. Column agglutination technology: the antiglobulin test. Transfusion. 1993;33:639-43.
Ranjan V, Khillan K. Naturally occurring anti-M with high thermal amplitude complicating ABO blood grouping. Curr Med Res Pract. 2018;8:71-2.
Samarah F, Srour M. An unusual report of anti-N antibody presenting as ABO discrepancy in an old female patient in Palestine. Asian J Transfus Sci. 2019;13:140-1.
Ferdowsi S, Mohammadi S, Ahmadnezhad M, Herfat F, Rezvani A, Eshghi P, et al. Naturally occurring anti-P1 with high thermal amplitude complicating ABO blood grouping. Asian J Transfus Sci. 2024;18:135-7.
Sathima L, Kulvara A, Pasuporn P. AB para-Bombay phenotype with anti-H a case report. J Hematol Transfus Med. 2019;29:131-7.
National Blood Centre, Thai Red Cross Society. National blood service operation plan of Thailand 2022–2027. 1st ed. Bangkok: Udomsuksa; 2021. p. 26-40.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Hematology and Transfusion Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.